Animal Antibiotics Market

Animal Antibiotics Market Size, Share, Growth Analysis, By Product Type (Tetracycline, Penicillin, Sulfonamide, Macrolide), By Mode of delivery (Premixes, Injection, Macrolide), By End Users (Poultry Farm, Dairy Farm, Other Livestock Farm), & Region - Global Review 2022 to 2032

Analysis of Animal Antibiotics Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Animal Antibiotics Market outlook (2022 to 2032)

Animal antibiotics are used by farmers to prevent animals from suffering from infectious diseases. They are added to animal feed to improve its efficiency as well as promote the growth of animals. The addition of animal antibiotics such as tetracycline and penicillin to the chicken feed improves egg production and hatchability without causing any mortality.

Moreover, penicillin is used for the treatment of pneumonia in cattle. Animals suffer from bacterial infections just like human beings. They need to be cared for and given time just like we do for our children. Animal antibiotics are used to prevent the disease from being established. It is important to know that the excess of anything is bad, and antibiotics are used either for the treatment of diseases or for their prevention.

Animal antibiotics are gaining ground in case of prevention and treatment of diseases in animals, primarily bacterial diseases. Antibiotics have evolved to be highly instrumental in treating dangerous and contagious diseases, which leads to a reduction of medicines intake in the latter stages of suffering. The use of animal antibiotics has emerged to be highly imperative in the animal welfare program, which is boosting the adoption rate of animal antibiotics. The high-scale implementation of ‘prevention is better than cure in the field of animal welfare is pushing the vigor of animal antibiotics.

The global animal antibiotics market at present is valued at USD 5.6 Billion in the year 2022. The animal antibiotics market is anticipated to grow with a CAGR of 3.6% in the forecast period. The market is further expected to surpass a valuation of USD 6.92 Billion by end of 2032.

Report Attributes

Details

Market size (2022A)

USD 5.6 Billion

Base Year for Estimation

2022

Forecast duration for this research

2022-2032

Forecasted Market value (2032F)

USD 6.92 Billion

Global Market Growth rate (2022-2032E)

CAGR of 3.6%

Key Companies Profiled

  • Huvepharma AD;
  • Merck & Co., Inc.;
  • Ceva Animal Health LLC;
  • Zoetis, Inc.;
  • Crystal Pharma and
  • Afrivet

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What are the factors that drive the growth of the Animal antibiotics market?

Animal antibiotics are driving the market due to the growing need to improve the efficiency, growth rate, and reproducibility of animals to fulfill the ever-increasing needs of the human population. The cost of maintaining animals is high, hence animal antibiotics are required to prevent diseases in animals. It is important to know whether an animal is suffering from any disease.

Furthermore, increased demand for dairy products and meat is driving the usage of animal antibiotics. However, due to changes in lifestyle and habits, there is an increase in the number of lactose-intolerant people. In addition, the conversion of non-vegetarians into vegetarians is affecting the growth of the animal antibiotics market.

Veterinarians and farmers are joining hands and working together to create health management programs to spread awareness about the prevention of diseases before they develop and spread. However, the World Health Organization (WHO) has recommended that food industries and farmers should reduce the routine usage of animal antibiotics to prevent antibiotic resistance in order to aid the healthy growth of animals as well as for the prevention of diseases.

What are the challenges associated with the use of animal antibiotics?

There are concerns associated with animal antibiotics which are resulting in antibiotic resistance in long term. The repetitive usage of antibiotics and prevention of diseases in animals often result in medicines that lead to resistance. The better use of vaccination and improved hygiene is the key concern of farmers and animal antibiotic producers.

The food-producing animals are carriers of pathogens which are latterly transmitted from animals to humans which may cause long terms illnesses and impel to food-borne diseases. Veterinarians recommend the use of less concentrated animal antibiotics in animal treatments across the globe.

The presence of stringent government regulations is creating hurdles for manufacturers in order to meet set quality standards. The global market for animal antibiotics is expected to witness moderate growth over the forecast period. Antibiotics keep the animals and the environment healthy. When animals suffer from diseases and are left untreated, they require more food and water, whereas healthy animals require fewer natural resources.

However, due to the misuse of drugs, they have entered the human food chain, which is causing antibiotic-resistant infections. Farmers and all those who domesticate animals for any purpose have a moral duty to protect them and take care of them, which includes the cautious use of antibiotics when the animals are suffering from diseases.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Segment wise Insights

On the basis of product type, the animal antibiotics market is segmented into penicillin, sulphonamides, and tetracyclines. In 2020 the share of tetracycline is dominant among all types accounting share of 48% in total sales. This tetracycline is widely used owing to its highest potency against pathogenic microbes.

The advantage of this product is accounted for a large share of product segments. Moreover, there is an anticipated rise in fluoroquinolones during the assessment period of this research owing to their efficiency during low concentration. These antibiotics are quick to penetrate through the tissues and are highly adopted by end users.

The premixes segment in terms of delivery modes dominated the animal antibiotics market. These are further categorized into oral solutions and injections. The premix segment owned a share of 45% in 2020. A large share of this segment is attributed to benefits and modes of administration. This segment is expected to see growth in upcoming years.

Regional Insights

The global animal antibiotics market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). North America is expected to dominate the global animal antibiotics market owing to the widespread availability of technological advancements and medical care.

The animal antibiotics market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by key players. Europe is expected to have the second-largest share in the global animal antibiotics market throughout the forecast period.

As per FAO South Asia is a major dairy production region in the world accounting for one-fourth of global dairy products. India is the largest country in Asia pacific in terms of dairy production followed by China. To maintain the livestock qualities and minimize the risk of diseases among animals, the animal husbandry industry in this region is dependent on animal antibiotics as health improvement products.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Key Segments of Animal Antibiotics Industry Research

The global animal antibiotics Industry can be segmented on the basis of product type, end-user, and geography.

  • By Product Type :

    • Tetracyclines
    • Penicillins
    • Macodolides
  • By End Users :

    • Poultry Farm
    • Dairy Farm
    • Other Livestock Farm
  • By Region:

    • North America
    • Latin America
    • Western Europe
    • Eastern Europe
    • Asia Pacific 
    • Japan
    • Middle East and Africa

Table of Content

1. Executive Summary

2. Industry Introduction, including Taxonomy and Market Definition

3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments

4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections

5. Pricing Analysis

6. Global Market Analysis and Forecast

    6.1. Product Type

    6.2. End Users

7. Global Market Analysis and Forecast, By Product Type

    7.1. Tetracyclines

    7.2. Penicillins

    7.3. Macodolides

8. Global Market Analysis and Forecast, By End Users

    8.1. Poultry Farm

    8.2. Dairy Farm

    8.3. Other Livestock Farm

9. Global Market Analysis and Forecast, By Region

    9.1. North America

    9.2. Latin America

    9.3. Western Europe

    9.4. Eastern Europe

    9.5. East Asia

    9.6. South Asia & Pacific

    9.7. MEA

10. North America Sales Analysis and Forecast, by Key Segments and Countries

11. Latin America Sales Analysis and Forecast, by Key Segments and Countries

12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries

13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries

14. East Asia Sales Analysis and Forecast, by Key Segments and Countries

15. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries

16. MEA Sales Analysis and Forecast, by Key Segments and Countries

17. Sales Forecast by Product Type and End Users for 30 Countries

18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard

19. Company Profile

    19.1. Huvepharma AD

    19.2. Merck & Co., Inc.

    19.3. Ceva Animal Health LLC

    19.4. Zoetis, Inc.

    19.5. Crystal Pharma

    19.6. Afrivet

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 1: Global Market US$ Bn Forecast by Region

Table 2: Global Market US$ Bn Forecast by Product Type

Table 3: Global Market US$ Bn Forecast by End Users

Table 4: North America Market US$ Bn Forecast by Country

Table 5: North America Market US$ Bn Forecast by Product Type

Table 6: North America Market US$ Bn Forecast by End Users

Table 7: Latin America Market US$ Bn Forecast by Country

Table 8: Latin America Market US$ Bn Forecast by Product Type

Table 9: Latin America Market US$ Bn Forecast by End Users

Table 10: Western Europe Market US$ Bn Forecast by Country

Table 11: Western Europe Market US$ Bn Forecast by Product Type

Table 12: Western Europe Market US$ Bn Forecast by End Users

Table 13: Eastern Europe Market US$ Bn Forecast by Country

Table 14: Eastern Europe Market US$ Bn Forecast by Product Type

Table 15: Eastern Europe Market US$ Bn Forecast by End Users

Table 16: East Asia Market US$ Bn Forecast by Country

Table 17: East Asia Market US$ Bn Forecast by Product Type

Table 18: East Asia Market US$ Bn Forecast by End Users

Table 19: South Asia & Pacific Market US$ Bn Forecast by Country

Table 20: South Asia & Pacific Market US$ Bn Forecast by Product Type

Table 21: South Asia & Pacific Market US$ Bn Forecast by End Users

Table 22: MEA Market US$ Bn Forecast by Country

Table 23: MEA Market US$ Bn Forecast by Product Type

Table 24: MEA Market US$ Bn Forecast by End Users

Table 25: Latin America Market US$ Bn Forecast by Country

Table 26: Latin America Market US$ Bn Forecast by Product Type

Table 27: Latin America Market US$ Bn Forecast by End Users

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type

Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users

Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Region

Figure 4: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type

Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users

Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country

Figure 7: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type

Figure 8: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users

Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country

Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type

Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users

Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country

Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type

Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users

Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country

Figure 16: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type

Figure 17: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users

Figure 18: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country

Figure 19: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type

Figure 20: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users

Figure 21: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country

Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type

Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users

Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country

Figure 25: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type

Figure 26: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users

Figure 27: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What is the future market outlook for the animal antibiotic market?

The market is further expected to surpass a valuation of USD 6.92 Billion by end of 2032.

What is the projected growth rate for the animal antibiotics market?

The animal antibiotics market is anticipated to grow with a CAGR of 3.6% in the forecast period.

How big is the animal antibiotic market at present?

The global animal antibiotics market at present is valued at USD 5.6 Billion in the year 2022.

Which type of mode is leading in the product delivery segment?

Premixes are dominating the mode of delivery of the animal antibiotic market.

Which geographical region is dominating the animal antibiotics arcade?

North America accounts for a major share of animal antibiotics arcade.

Animal Antibiotics Market

Schedule a Call